DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Heymach JV, Paz-Ares L, De Braud F et al.
Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer.
J Clin Oncol 2008;
26: 5407-5415
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.